인쇄하기
취소

Bill to simplify commercialization of ACT proposed

Published: 2009-10-16 06:57:00
Updated: 2009-10-16 06:57:00
A lawmaker has proposed a bill to let an autologous cell therapy commercialize with Phase I clinical trial only, holding a promise to patients with rare or life-threatening diseases.

Under the proposed bill, a drug maker who intends to market ACT will get a product license with approval of Phase I pharmacology data only, while omitting other data submission related to Phase II and III trials...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.